Method for optimizing a biopharmaceutical production process

Details for Australian Patent Application No. 2010332766 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Schlatter, Stefan; Sauter, Christian; Probst, Eugen; Wiedemann, Franz; Guelch, Carina

Agent Spruson & Ferguson

Pub. Number AU-A-2010332766

PCT Pub. Number WO2011/073377

Priority 09179954.4 18.12.09 EP; 10161272.9 28.04.10 EP

Filing date 17 December 2010

Wipo publication date 23 June 2011

International Classifications

C12N 5/00 Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/073377 Priority application(s): WO2011/073377

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010332767-Tricyclic antibiotics

2010332765-Pyrrolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of G-Protein Coupled Receptor 43 (GPR43)